BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9138445)

  • 1. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI.
    García CO; Kanbour-Shakir A; Tang H; Molina JF; Espinoza LR; Gharavi AE
    Am J Reprod Immunol; 1997 Jan; 37(1):118-24. PubMed ID: 9138445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I.
    Aron AL; Cuellar ML; Brey RL; Mckeown S; Espinoza LR; Shoenfeld Y; Gharavi AE
    Clin Exp Immunol; 1995 Jul; 101(1):78-81. PubMed ID: 7621596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of antiphospholipid antibodies: induction of aPL by viral peptides.
    Gharavi AE; Pierangeli SS
    Lupus; 1998; 7 Suppl 2():S52-4. PubMed ID: 9814674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
    Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
    Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death.
    Silver RM; Pierangeli SS; Gharavi AE; Harris EN; Edwin SS; Salafia CM; Branch DW
    Am J Obstet Gynecol; 1995 Nov; 173(5):1410-5. PubMed ID: 7503178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
    Blank M; Waisman A; Mozes E; Koike T; Shoenfeld Y
    Int Immunol; 1999 Dec; 11(12):1917-26. PubMed ID: 10590257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
    Blank M; Faden D; Tincani A; Kopolovic J; Goldberg I; Gilburd B; Allegri F; Balestrieri G; Valesini G; Shoenfeld Y
    J Autoimmun; 1994 Aug; 7(4):441-55. PubMed ID: 7980847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
    Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
    Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?
    Erkan D; Barbhaiya M; George D; Sammaritano L; Lockshin M
    Lupus; 2010 Apr; 19(5):613-9. PubMed ID: 19934177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis.
    Papalardo E; Romay-Penabad Z; Willis R; Christadoss P; Carrera-Marin AL; Reyes-Maldonado E; Rudrangi R; Alfieri-Papalardo S; Garcia-Latorre E; Blank M; Pierangeli S; Brasier AR; Gonzalez EB
    Arthritis Rheumatol; 2017 Oct; 69(10):2052-2061. PubMed ID: 28666081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
    Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
    Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.